Publications by authors named "Mike Russell"

Claim this Profile
D
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast Cancer.
Guozhang Xu, Courtney G Havens, Qiaolin Deng, Cassandra Lowenstein, Debangshu Samanta, Mike Russell

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of population-based recovery actions for threatened southern mountain caribou.
Clayton T Lamb, Sara Williams, Stan Boutin, Michael Bridger, Deborah Cichowski, Mike Russell

Ecol Appl· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pilot Study of Nutritional Supplementation in Soft Tissue Sarcoma Patients.
Mike Russell, Steven Leary, Nathan E Saxby, Natalie Glass, Benjamin J Miller

Iowa Orthop J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-based application for threatened woodland caribou population modeling.
Daniel R Eacker, Mark Hebblewhite, Robin Steenweg, Mike Russell, Amy Flasko

Wildl Soc Bull· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma.
Mario Capasso, Lee D McDaniel, Flora Cimmino, Andrea Cirino, Daniela Formicola, Mike R Russell

J Cell Mol Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Therapeutic Synergy of MEK1/2 and CDK4/6 Inhibition in Neuroblastoma.
Lori S Hart, JulieAnn Rader, Pichai Raman, Vandana Batra, Mike R Russell

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus.
Mike R Russell, Annalise Penikis, Derek A Oldridge, Juan R Alvarez-Dominguez, Lee McDaniel

Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare variants in TP53 and susceptibility to neuroblastoma.
Sharon J Diskin, Mario Capasso, Maura Diamond, Derek A Oldridge, Karina Conkrite, Mike R Russell

J Natl Cancer Inst· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual CDK4/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma.
Julieann Rader, Mike R Russell, Lori S Hart, Michael S Nakazawa, Lili T Belcastro

Clin Cancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-1β promotes skeletal colonization and progression of metastatic prostate cancer cells with neuroendocrine features.
Qingxin Liu, Mike R Russell, Kristina Shahriari, Danielle L Jernigan, Mercedes I Lioni

Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastoma.
Mike R Russell, Kirill Levin, JulieAnn Rader, Lili Belcastro, Yimei Li

Cancer Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi screen of the protein kinome identifies checkpoint kinase 1 (CHK1) as a therapeutic target in neuroblastoma.
Kristina A Cole, Jonathan Huggins, Michael Laquaglia, Chase E Hulderman, Mike R Russell

Proc Natl Acad Sci U S A· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the {alpha} receptor for platelet-derived growth factor as a primary or combination therapy in a preclinical model of prostate cancer skeletal metastasis.
Mike R Russell, Qingxin Liu, Alessandro Fatatis

Clin Cancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic and phenotypic variation in heartwood and essential-oil characters in natural populations of Santalum austrocaledonicum in Vanuatu.
Tony Page, Ian Southwell, Mike Russell, Hanington Tate, Joseph Tungon

Chem Biodivers· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.
Mike R Russell, Qingxin Liu, Hetian Lei, Andrius Kazlauskas, Alessandro Fatatis

Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.
Nathan G Dolloff, Mike R Russell, Nick Loizos, Alessandro Fatatis

Cancer Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic consequences of constraining running behavior.
John A Mercer, Neil E Bezodis, Mike Russell, Andy Purdy, David Delion

J Sports Sci Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis